Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.49 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.49 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.49 |
| ▸ | MAOB | P27338 | 11/20 | 0.49 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | TNKS | O95271 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.42 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11643109 | 0.84 | MAOB (0.54) | CSNK2A2CSNK2BCSNK2A1MAOBMAOA | |
| SCHEMBL12279182 | 0.81 | MAOA (0.58) | CSNK2A2CSNK2BCSNK2A1MAOBMAOA | |
| SCHEMBL12279276 | 0.81 | MAOB (0.50) | CSNK2A2CSNK2BCSNK2A1MAOBMAOA | |
| SCHEMBL19683576 | 0.79 | MAOB (0.60) | MAOBMAOAESR1ESR2TNKS | |
| SCHEMBL12277884 | 0.77 | MAOB (0.53) | CSNK2A2CSNK2BCSNK2A1MAOBESR1 | |
| SCHEMBL12278552 | 0.77 | MAOB (0.53) | CSNK2A2CSNK2BCSNK2A1MAOBESR1 | |
| SCHEMBL14231895 | 0.77 | CYP1A2 (0.48) | MAOBMAOA | |
| SCHEMBL12278608 | 0.76 | CYP1A1 (0.60) | CSNK2A2CSNK2BCSNK2A1MAOBMAOA | |
| SCHEMBL12278684 | 0.75 | CYP1A1 (0.55) | CSNK2A2CSNK2BCSNK2A1MAOBMAOA | |
| SCHEMBL12279280 | 0.74 | HSD17B10 (0.42) | ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785915-B2 | Compound for organic thin film transistor and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8785915-B2 | Compound for organic thin film transistor and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) | 2011-09-01 | — | — | US | disclosed |
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | OR10J3, TCF4, CTCF | CSNK2A2 4570/4885CSNK2B 4636/4885CSNK2A1 4675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.